SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bayalagmaa Nyamaa, Hyoung Kyu Kim, Yu Jeong Jeong, In-Sung Song, Jin Han, Kinesin Spindle Protein Inhibition in Translational Research, Journal of Lipid and Atherosclerosis, 2014, 3, 2, 63

    CrossRef

  2. 2
    Harris Wang, The Vo, Ali Hajar, Sarah Li, Xinmei Chen, Amadeo M Parissenti, David N Brindley, Zhixiang Wang, Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells, BMC Cancer, 2014, 14, 1, 37

    CrossRef

  3. 3
    Tahereh Fatemian, Iekhsan Othman, Ezharul Hoque Chowdhury, Strategies and validation for siRNA-based therapeutics for the reversal of multi-drug resistance in cancer, Drug Discovery Today, 2014, 19, 1, 71

    CrossRef

  4. 4
    Xinran Liu, Hao Gong, Kun Huang, Oncogenic role of kinesin proteins and targeting kinesin therapy, Cancer Science, 2013, 104, 6
  5. 5
    L J Monteiro, P Khongkow, M Kongsema, J R Morris, C Man, D Weekes, C-Y Koo, A R Gomes, P H Pinto, V Varghese, L M Kenny, R Charles Coombes, R Freire, R H Medema, E W-F Lam, The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment, Oncogene, 2013, 32, 39, 4634

    CrossRef

  6. 6
    Alberto J. Montero, Jacek Jassem, Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer, Drugs, 2011, 71, 11, 1385

    CrossRef

  7. 7
    Van Nguyen, Jesse M. Conyers, Dongqin Zhu, Denise M. Gibo, Jay F. Dorsey, Waldemar Debinski, Akiva Mintz, IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications, Translational Oncology, 2011, 4, 6, 390

    CrossRef